108-78-1

应用筛选条件

关键词:'108-78-1'

显示 31-60 共 118 条结果关于 "108-78-1" 范围技术文档

Piribedil maleate Q-102 (-)-Quinpirole hydrochloride Q-110 Quinelorane dihydrochloride R-108 Ro 41-0960 D-017 3-Hydroxyphenethylamine hydrochloride R-121 S(+)-Raclopride L-tartrate R-

Product Information - L6412

Piribedil maleate Q-102 (-)-Quinpirole hydrochloride Q-110 Quinelorane dihydrochloride R-108 Ro 41-0960 D-017 3-Hydroxyphenethylamine hydrochloride R-121 S(+)-Raclopride L-tartrate R-

Product Information Sheet - 11585584001

ng 77% 1.1 × 109 75% 2 × 109 72% 2.8 × 109 incorporation dpm/�g 100 ng 79% 3.2 ×108 78% 7.3 × 108 77% 1.3 × 109 incorporation dpm/�g 1000 ng 63% 6.8 × 107 incorporation dpm/�g

Product Information Sheet - 11585592001

25 ng 77% 1.1 × 109 75% 2 x 109 72% 2.8 × 109 incorporation dpm/�g 100 ng 79% 78% 7.3 × 108 77% 1.3 × 109 incorporation dpm/�g 1000 ng 63% 6.8 × 107 incorporation dpm/�g

Product Information Sheet - RAB0228

). This IGF-1 ELISA kit shows no cross-reactivity with any of the cytokines tested: Human Angiogenin, BDNF, BLC, ENA-78, FGF-4, IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IL-1, IL-1, IL-2, IL-3, IL

Lymphocyte Enzymes Procedure

may be stored in liquid nitrogen (LN2) for control purposes. To accomplish this, 1 x 107 - 108 cells are frozen at 1 ± 0.3°C per minute in a medium containing 50% fetal calf serum, 40% RPMI-1640 (or

Product Information Sheet-11585592001

mmol 25 77% 1.1 × 109 75% 2 × 109 72% 2.8 × 109 incorporation dpm/µg 100 79% 78% 7.3 × 108 77% 1.3 × 109 1,000 – 63% 6.8

Product Information Sheet - RAB0248

99.67 90-108 Linearity:

Immobilization of Protein to Millipore 96-Well Membrane-Bottom Plates

. Bibliography (1) Kuno, H. and Kihara, H.K., Nature 215: pp 974-975 (1967). (2) Wallis, C., and Melnick, J., J. Viral. 1: pp 472-477 (1967). (3) Schneider, A., Anal. Biochem. 108: pp 96-103 (1980).

PKH Dye Reference Guide

163 Differentiation 1, 11, 33, 70, 80, 107, 137 Proliferation 1-3, 16, 18, 30, 36, 58, 62, 78, 91-93, 124, 125, 133 Conjugate formation, adhesion, and/or fusion 1-3, 12, 34, 60

Product Information Sheet - MPAA3

pSer73) 73 2 1 3 1 AP-1 74 2 1 3 2 AP-1 75 2 1 3 3 Protein Phosphatase 1α 76 2 1 3 4 Protein Phosphatase

Product Information - CSAA1

4f5 N9527 Nuclear M y y y 77 Topoisomerase-1 clone MAB1 T8573 Nuclear M y n/d n/d 78 Trf-1 CloneTRF-78 T1948 Nuclear M

Quantitative PCR Using SYBR Green JumpStart Ta qReadyMix: Lights Your Way to Quantitative PCR and RT-PCR

1.6 1.5 1.4 1.3 1.2 1.1 1 0.9 0.8 0.7 0.6 0.4 0.3 0.2 0.1 0 –0.1 –0.2 0.5 64 66 68 70 72 74 76 78 80 82 84 86 88 90 –0.3 Fl u o re sc en ce -d (F 1) /d T Temperature (

Product Information Sheet - 11666851001

 The antibody preparation does not contain pre- servatives or stabilizers. Affinity Ka = 1 × 108/M Isoelectric Point 6.4 2. How to Use this Product 2.1 Before You Begin Epitope Tagging

Product Information Sheet - ROAHA

HPLC.  The antibody preparation does not contain pre- servatives or stabilizers. Affinity Ka = 1 × 108/M Isoelectric Point 6.4 2. How to Use this Product 2.1 Before You Begin Epitope Tagging

User Guide - 11741985001

sample volume). In this case 350 µl lysis buffer (vial 1) have to be added to get the required final volume of 400 µl. Number of cells 1 × 108 2 × 107 1 × 107 2 × 106 2 ×

ChemiScreen™ Flash Aequorin Calcium-Optimized Stable Cell Line Human Recombinant EP4 Prostanoid Receptor

function. J. Clin. Invest. 108: 25-30. Nguyen M et al. (1997) The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390: 78-81. Yoshida K et al. (2002

Bioactive Lipids Technical Bulletin

et al. 1994. Pediatr. Pulmonol. 18, 129. 7. Iwamoto, I., et al. 1995. Int. Arch. Allergy Immunol. 108, 68. 8. Jedlitschky, G., et al. 1991. J. Biol. Chem. 266, 24763. 9. Henderson, W.R., Jr. 1994. Ann.

Product Information Sheet - NXTRACT

cells, from 20-100 µL of packed cell volume), or from a much larger number of cells (108–1010 cells, from ~1 mL of packed cell volume). Nuclear proteins can be extracted from the following fresh

Product Information Sheet - MI0500

solution 1:500. A.2 Microtubule preparation from cells 6-8 Tubulin preparation from cells requires a large amount of cells. The procedure below is directed for at least 6 X 108 cells. 1. Add cold

Protein Tyrosine Phosphatases- Potential Roles in Disease

number of proliferative diseases, particu- larly in cancer. There are three Cdc25 homologs: A, B and C [108], which are expressed and activated at different times during the cell cycle acting on different cyclin-Cdk

Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate

F 0 (Basal) 75 -- 78 -- 40 115 100% 114 90% 100 167 92% 167 89% 500 566 98% 572 99% I

Mouse Metabolic Hormone Expanded Panel

C-Peptide 2 100% Ghrelin 100% GIP 94% GLP-1 Active 88% GLP-1 Total 91% Glucagon 91% IL-6 101% Insulin 98% Leptin 108% MCP-1

Protocol: Human Circulating Cancer Biomarker Magnetic Bead Panel 1

61 CYFRA 21-1 63 OPN 64 FGF2 67 β-HCG 73 HE4 75 TGFα 76 VEGF 78

Ovine Cytokine/Chemokine Panel 1

BTNFA-MAG ✔ Anti-Bovine VEGF-A 78 ✔ BVEGFA-MAG ✔ SCYT1-91K Rev. 19-May-2020 PAGE 7 EMD Millipore MATERIALS REQUIRED BUT NOT PROVIDED Reagents 1. Luminex®

Protocol- MMHE-44K

Ghrelin (active) 100% GIP (total) 94% GLP-1 (active) 88% GLP-1 (total) 91% Glucagon 91% IL-6 101% Insulin 98% Leptin 108% MCP-1/CCL2 100%

Amidine-Based Catalysts (ABCs)- Design Development and Applications

24 h O OH Me R 6 examples, 70–93% dr > 19:1 in all cases 84 to >98% ee MeO2C Me OMeO2C 1. LiHMDS (1.0 equiv), THF, –78 to 0

Protocol: Glucagon-Like Peptide-1 (Total) RIA Kit

10 38 39 97 3 50 41 79 90 4 100 108 129 94 Varying concentrations of GLP-1 were spiked into four human plasma samples and the GLP-1 content determined by RIA.

Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease

Pediatr., 47, 117-160 (2000). 107. Shaham, Y., et al., Psychopharmacology (Berl), 137, 184-190 (1998). 108. Timpl, P., et al., Nat. Genet., 19, 162-166 (1998). 109. Adinoff, B., et al., Neuropsychopharmacology

59505 Galactosyltransferase Kit

1990, 102, 78. 59 C. Unverzagt, et al., J. Am. Chem. Soc., 1990, 112, 9308. 60 C. Augé, et al., Carbohydr. Res., 1989, 193, 288. 61 G. Baisch, R. Öhrlein,, Angew. Chem., 1996, 108

2/4